ARCHIVES

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Grants: UT Southwestern, M.D. Anderson Win Lung Cancer SPORE

December 6, 1996

Oxford Univ. Receives Funds To Create Drug Design Center.

October 6, 2000

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

November 4, 2011

In Brief: NIH Reviewers, Advisors To Get Increase In Honoraria; Price Leaving NCI for Maryland

March 14, 1980

Barnett Kramer Next Director Of NCI Division of Cancer Prevention

July 29, 2011